Visual storytelling for medical publications
2022-08-22 16:56
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
#Mepolizumab
reduced the number of exacerbations in
#urban
#children
with exacerbation-prone eosinophilic
#asthma
,
#MUPPITS2
study finds
https://bit.ly/3plfXTy
#VisualAbstract
#DataViz
#USA
#eosinophilicasthma
#in
@mdwrtcom